Dr. Lal PathLabs Limited (NSEI: LALPATHLAB)
Health Care · Health Care Providers & Services · IN
Rs1,894.20
-1.15% today · +12.8% 1Y
Dr. Lal PathLabs Limited (NSEI: LALPATHLAB) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $3.31B and employs 5,206 people.
Over the last twelve months the share price has gained 12.8%, trading between 1.27K and 1.99K.
Tweenvest scores Dr. Lal PathLabs Limited across four factors: quality 94/100, value 26/100, growth 63/100, dividend 70/100. Its strongest factor is quality.
LALPATHLAB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.31B
- Revenue (TTM)
- $305.74M
- P/E
- 58.46
- EPS
- 32.40
- Dividend yield
- 1.06%
- Beta (5Y)
- 0.19
- 52-week high
- Rs1,988.90
- 52-week low
- Rs1,272.60
- Avg volume (3M)
- —
- Shares outstanding
- 167.06M
- Employees
- 5,206
- Next earnings
- —
About Dr. Lal PathLabs Limited
Dr. Lal PathLabs Limited is a leading provider of diagnostic and related health assessment services, operating both domestically in India and across international borders. The company manages a comprehensive network of laboratories dedicated to conducting pathological investigations across various specialized fields. These include biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, in addition to other general pathological and radiological studies. Beyond its core testing operations, Dr. Lal PathLabs also offers laboratory staff training, technical support, and full-scale lab management services. As of March 31, 2022, its widespread infrastructure included 277 clinical laboratories, notably a National Reference Lab located in Delhi and a Regional Reference Lab in Kolkata. This is further bolstered by 4,731 patient service centers and 10,599 sample collection points. Founded in 1949, Dr. Lal PathLabs Limited maintains its corporate base in Gurugram, India.
- ISIN
- INE600L01024
- Founded
- 1949
- Listed since
- Dec 23, 2015
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $357.92B | $398.76 | +2.22% |
| CVS Health CorporationNYSE: CVS | $120.36B | $94.11 | +1.17% |
| McKesson CorporationNYSE: MCK | $101.88B | $873.79 | +1.73% |
| HCA Healthcare, Inc.NYSE: HCA | $92.93B | $429.24 | +0.01% |
| Elevance Health, Inc.NYSE: ELV | $87.32B | $402.63 | +0.52% |
| The Cigna GroupNYSE: CI | $74.11B | $280.45 | +1.06% |
| Cencora, Inc.NYSE: COR | $61.78B | $323.77 | +1.80% |
| Cardinal Health, Inc.NYSE: CAH | $54.04B | $232.37 | +1.25% |
Figures last refreshed Aug 18, 2026.